Birchview Capital’s Zentalis Pharmaceuticals ZNTL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $19.7K | Hold |
17,000
| – | – | 0.02% | 70 |
|
|
2025
Q1 | $27K | Hold |
17,000
| – | – | 0.02% | 68 |
|
|
2024
Q4 | $51.5K | Buy |
17,000
+1,000
| +6% | +$3.03K | 0.04% | 66 |
|
|
2024
Q3 | $58.9K | Hold |
16,000
| – | – | 0.05% | 58 |
|
|
2024
Q2 | $65.4K | Hold |
16,000
| – | – | 0.06% | 58 |
|
|
2024
Q1 | $252K | Hold |
16,000
| – | – | 0.21% | 49 |
|
|
2023
Q4 | $242K | Buy |
+16,000
| New | +$242K | 0.19% | 47 |
|
|
2022
Q3 | – | Sell |
-8,000
| Closed | -$225K | – | 65 |
|
|
2022
Q2 | $225K | Hold |
8,000
| – | – | 0.16% | 49 |
|
|
2022
Q1 | $369K | Hold |
8,000
| – | – | 0.27% | 45 |
|
|
2021
Q4 | $672K | Hold |
8,000
| – | – | 0.43% | 38 |
|
|
2021
Q3 | $533K | Hold |
8,000
| – | – | 0.36% | 39 |
|
|
2021
Q2 | $426K | Buy |
+8,000
| New | +$426K | 0.25% | 46 |
|